Statins may cut death risk in breast cancer patients

04/24/2013 | Family Practice News

An analysis of data from more than 30,000 breast cancer patients in Finland showed that statin use before and after diagnosis was linked to reduced mortality risk of up to 66%. "The association held for both localized and metastatic tumors. There really appears to be something going on here, and it's certainly a reason for further study," a researcher said. The findings were presented at the annual meeting of the American Association for Cancer Research.

View Full Article in:

Family Practice News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA